On October 24, 2017 Array BioPharma Inc. (Nasdaq: ARRY) reported that it will report financial results for the first quarter of fiscal 2018 and hold a conference call to discuss those results on Tuesday, October 31, 2017 (Press release, Array BioPharma, OCT 24, 2017, View Source [SID1234521119]). Ron Squarer, Chief Executive Officer, will lead the call.